Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics (CRSP)
:CRSP
Crispr Therapeutics AG (CRSP) Ownership Overview
1.68% Insiders
17.12% Mutual Funds
42.71% Other Institutional Investors
17.38% ETFs
21.11% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 77.21% of the company’s stock is owned by Institutional Investors, 1.68% is owned by Insiders, and 21.11% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 28, 2025 | xxxxxxxxxxxxx | $313880 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $345928562 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,165,400 | Institution | 11.77% | 369,105,674 | |
| 9,096,158 | Institution | 10.53% | 330,281,497 | |
| 4,791,184 | Institution | 5.55% | 173,967,891 | |
| 1,849,009 | Institution | 2.14% | 67,137,517 | |
| 1,619,509 | Institution | 1.88% | 58,804,372 | |
| 1,603,795 | Institution | 1.86% | 58,233,796 | |
| 1,495,000 | Institution | 1.73% | 54,283,450 | |
| 1,287,261 | Institution | 1.49% | 46,740,447 | |
| 1,202,664 | Institution | 1.39% | 43,668,730 | |
| 1,048,951 | Insider | 1.21% | 38,087,411 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,791,184 | Institution | 5.55% | 173,967,891 | |
| 1,619,509 | Institution | 1.88% | 58,804,372 | |
| 1,495,000 | Institution | 1.73% | 54,283,450 | |
| 1,287,261 | Institution | 1.49% | 46,740,447 | |
| 958,186 | Institution | 1.11% | 34,791,734 | |
| 937,284 | Institution | 1.09% | 34,032,782 | |
| 844,226 | Institution | 0.98% | 30,653,846 | |
| 689,399 | Institution | 0.80% | 25,032,078 | |
| 351,358 | Institution | 0.41% | 12,757,809 | |
| 333,855 | Institution | 0.39% | 12,122,275 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,731,325 | Institution | 7.79% | 244,414,411 | |
| 2,004,457 | Institution | 2.32% | 72,781,834 | |
| 1,772,632 | Institution | 2.05% | 63,105,699 | |
| 1,332,982 | Institution | 1.54% | 51,546,414 | |
| 511,424 | Institution | 0.59% | 18,569,805 | |
| 409,480 | Institution | 0.47% | 14,577,488 | |
| 364,474 | Institution | 0.42% | 12,975,274 | |
| 253,584 | Institution | 0.29% | 9,806,093 | |
| 226,888 | Institution | 0.26% | 8,077,213 | |
| 103,124 | Institution | 0.12% | 3,744,432 |
FAQ
Who Owns Crispr Therapeutics (CRSP)?
According to the latest TipRanks data, approximately 42.71% of the company's stock is held by institutional investors, 1.68% is held by insiders, and 21.11% is held by retail investors.
What percentage of Crispr Therapeutics (CRSP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 42.71% of Crispr Therapeutics (CRSP) stock is held by institutional investors.
What percentage of Crispr Therapeutics (CRSP) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.11% of Crispr Therapeutics (CRSP) stock is held by retail investors.
Who owns the most shares of Crispr Therapeutics (CRSP)?
Cathie Wood owns the most shares of Crispr Therapeutics (CRSP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.